Scinovex
article Open AccessTop 1% cited

Estimating the financial cost of chronic kidney disease to the NHS in England

Nephrology Dialysis Transplantation · 2012 · Vol. 27(suppl_3) · pp. iii73–iii80
Marion KerrBenjamin BrayJames MedcalfDónal O’DonoghueBeverley Matthews

Abstract

The financial impact of CKD is large, with particularly high costs relating to RRT and cardiovascular complications. It is hoped that these detailed cost estimates will be useful in analysing the cost-effectiveness of treatments for CKD.

Healthcare cost, quality, practicesChronic Kidney Disease and DiabetesDialysis and Renal Disease ManagementMedicineKidney diseaseHealth careHealthcare systemDiseaseIntensive care medicineFamily medicineEnvironmental healthInternal medicineEconomic growth

MeSH terms

Cardiovascular DiseasesCost-Benefit AnalysisFollow-Up StudiesGlomerular Filtration RateUnited KingdomHumansNational Health ProgramsPrognosisCohort StudiesPrevalenceCost of IllnessRenal Replacement TherapyModels, EconomicRenal Insufficiency, Chronic
Citations
363
FWCI
42.41
field-weighted impact
References
25
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Estimating the financial cost of chronic kidney disease to the NHS in England · Scinovex